CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2026-02-25 11:47Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Xiangsheng Medical (688358), indicating a slight increase in stock price and a mixed financial outlook for the company [1][2]. Group 2 - As of February 25, 2026, Xiangsheng Medical's stock closed at 34.57 yuan, with a 0.93% increase, a turnover rate of 1.09%, a trading volume of 12,200 shares, and a transaction amount of 41.99 million yuan [1]. - On February 25, the net inflow of main funds was 2.57 million yuan, accounting for 6.13% of the total transaction amount, while retail investors experienced a net outflow of 0.12 million yuan, representing 0.29% of the total [1]. - For the first three quarters of 2025, the company reported a main revenue of 343 million yuan, a year-on-year decrease of 5.27%, and a net profit attributable to shareholders of 93.92 million yuan, down 4.56% year-on-year [2]. - In Q3 2025, the company achieved a single-quarter main revenue of 107 million yuan, a decline of 6.68% year-on-year, but the net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [2]. - The company has a debt ratio of 11.24%, with investment income of 3.01 million yuan and financial expenses of -16.53 million yuan, while maintaining a gross profit margin of 59.82% [2]. - Xiangsheng Medical specializes in the research, manufacturing, and sales of ultrasound medical imaging equipment, providing various ultrasound medical imaging devices and professional technical development services to domestic and international medical institutions and research organizations [2]. Group 3 - In the last 90 days, three institutions have given buy ratings for Xiangsheng Medical, indicating positive sentiment among analysts [3].